<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:21:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9331093" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9331093</identifier>
        <datestamp>2022-08-16</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9331093</article-id>
              <article-id pub-id-type="pmcid">PMC9331093</article-id>
              <article-id pub-id-type="pmc-uid">9331093</article-id>
              <article-id pub-id-type="pmid">35895056</article-id>
              <article-id pub-id-type="pmid">35895056</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2022.24142</article-id>
              <article-id pub-id-type="publisher-id">zoi220679</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Geriatrics</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Comparison of Functional and Structural Neural Network Features in Older Adults With Depression With vs Without Apathy and Association With Response to Escitalopram</article-title>
                <subtitle>Secondary Analysis of a Nonrandomized Clinical Trial</subtitle>
                <alt-title alt-title-type="headline">Functional and Structural Neural Network Features in Older Adults With Depression With or Without Apathy</alt-title>
                <alt-title alt-title-type="running-head">Functional and Structural Neural Network Features in Older Adults With Depression With or Without Apathy</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Oberlin</surname>
                    <given-names>Lauren E.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi220679aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Victoria</surname>
                    <given-names>Lindsay W.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi220679aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ilieva</surname>
                    <given-names>Irena</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dunlop</surname>
                    <given-names>Katharine</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hoptman</surname>
                    <given-names>Matthew J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220679aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <xref rid="zoi220679aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Avari</surname>
                    <given-names>Jimmy</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi220679aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alexopoulos</surname>
                    <given-names>George S.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi220679aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Gunning</surname>
                    <given-names>Faith M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220679aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi220679aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zoi220679aff1"><label>1</label>Department of Psychiatry, Weill Cornell Medicine, New York, New York</aff>
              <aff id="zoi220679aff2"><label>2</label>Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, New York</aff>
              <aff id="zoi220679aff3"><label>3</label>Clinical Research Division, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York</aff>
              <aff id="zoi220679aff4"><label>4</label>Department of Psychiatry, NYU Grossman School of Medicine, New York, New York</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> June 13, 2022.</p>
                <p content-type="published-online"><bold>Published:</bold> July 27, 2022. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2022.24142</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. © 2022 Oberlin LE et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zoi220679cor1"><bold>Corresponding Author:</bold> Faith M. Gunning, PhD, Institute of Geriatric Psychiatry, Weill Cornell Medicine, 21 Bloomingdale Rd, 7 South, Room 102, White Plains, NY 10605 (<email xlink:href="fgd2002@med.cornell.edu">fgd2002@med.cornell.edu</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Oberlin had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
                <p><italic>Concept and design:</italic> Oberlin, Alexopoulos, Gunning.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> Oberlin, Victoria, Ilieva, Dunlop, Hoptman, Avari, Gunning.</p>
                <p><italic>Drafting of the manuscript:</italic> Oberlin, Alexopoulos, Gunning.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> Oberlin, Victoria, Ilieva, Dunlop, Hoptman, Avari, Gunning.</p>
                <p><italic>Statistical analysis:</italic> Oberlin, Dunlop, Gunning.</p>
                <p><italic>Obtained funding:</italic> Alexopoulos, Gunning.</p>
                <p><italic>Administrative, technical, or material support:</italic> Victoria, Ilieva, Hoptman, Avari, Gunning.</p>
                <p><italic>Supervision:</italic> Victoria, Hoptman, Avari, Alexopoulos, Gunning.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Dunlop reported receiving grants from the Canadian Institutes of Health Research outside the submitted work. Dr Hoptman reported receiving grants from a National Institute of Mental Health subcontract award during the conduct of the study; nonfinancial support from Brain Sciences; and grants from the American Foundation for Suicide Prevention outside the submitted work. Dr Alexopoulos reported receiving grants from Weill Cornell Medicine during the conduct of the study and receiving personal fees from Janssen, Eisai, and Otsuka; serving on the speakers bureaus of Takeda, Lundbeck, Otsuka, and Sunovion; and serving on the advisory boards of Janssen and Eisai outside the submitted work. Dr Gunning reported receiving grants from the National Institute of Mental Health during the conduct of the study and grants from Akili Interactive. No other disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This work was supported by grants R01 MH097735 (Dr Gunning) and T32 MH019132-30 (Dr Alexopoulos) from the National Institute of Mental Health.</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The National Institute of Mental Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2022-07-27T10:00">
                <day>27</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>27</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>5</volume>
              <issue>7</issue>
              <elocation-id>e2224142</elocation-id>
              <history>
                <date date-type="received">
                  <day>13</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>13</day>
                  <month>6</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2022 Oberlin LE et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2224142.pdf">jamanetwopen-e2224142.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.24142"/>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-zoi220679-1">
                  <title>Question</title>
                  <p>What are the brain network features of apathy in late-life depression, and how are they associated with treatment outcomes?</p>
                </sec>
                <sec id="ab-zoi220679-2">
                  <title>Findings</title>
                  <p>In this secondary analysis of a 12-week nonrandomized single-group trial of escitalopram titrated to 20 mg/d, compared with 20 older adults with depression without apathy, 20 older adults with depression and apathy showed distinct alterations in network connectivity among circuits that support goal-directed behavior. Apathy-related variability in functional connectivity was associated with poor antidepressant response and persistent cognitive dysfunction after escitalopram treatment.</p>
                </sec>
                <sec id="ab-zoi220679-3">
                  <title>Meaning</title>
                  <p>This study suggests that, among older adults with depression, distinct network abnormalities may be associated with apathy and poor response to first-line pharmacotherapy and may serve as promising targets for novel interventions.</p>
                </sec>
              </abstract>
              <abstract>
                <sec id="ab-zoi220679-4">
                  <title>Importance</title>
                  <p>Apathy is prevalent among individuals with late-life depression and is associated with poor response to pharmacotherapy, including chronicity and disability. Elucidating brain networks associated with apathy and poor treatment outcomes can inform intervention development.</p>
                </sec>
                <sec id="ab-zoi220679-5">
                  <title>Objectives</title>
                  <p>To assess the brain network features of apathy among individuals with late-life depression and identify brain network abnormalities associated with poor antidepressant response.</p>
                </sec>
                <sec id="ab-zoi220679-6">
                  <title>Design, Setting, and Participants</title>
                  <p>This secondary analysis of a single-group, open-label nonrandomized clinical trial of escitalopram conducted at an outpatient geriatric psychiatry clinic enrolled 40 adults aged 59 to 85 years with major depressive disorder from July 1, 2012, to July 31, 2019.</p>
                </sec>
                <sec id="ab-zoi220679-7">
                  <title>Interventions</title>
                  <p>After a 2-week washout period, participants received escitalopram titrated to a target of 20 mg/d for 12 weeks.</p>
                </sec>
                <sec id="ab-zoi220679-8">
                  <title>Main Outcomes and Measures</title>
                  <p>Baseline and posttreatment magnetic resonance imaging (MRI), clinical, and cognitive assessments were conducted. Functional MRI was used to map group differences in resting state functional connectivity (rsFC) of the salience network, and diffusion MRI connectometry was performed to evaluate pathway-level disruptions in structural connectivity. The Apathy Evaluation Scale was used to quantify apathy, and the Hamilton Depression Rating Scale (HAM-D) was used to quantify the primary outcome of depression severity.</p>
                </sec>
                <sec id="ab-zoi220679-9">
                  <title>Results</title>
                  <p>Forty participants (26 women [65%]; mean [SD] age, 70.0 [6.6] years [range, 59-85 years]) with depression were included; 20 participants (50%) also had apathy. Relative to nonapathetic participants with depression, those with depression and apathy had lower rsFC of salience network seeds with the dorsolateral prefrontal cortex (DLPFC), premotor cortex, midcingulate cortex, and paracentral lobule and greater rsFC with the lateral temporal cortex and temporal pole (<italic>z</italic> score &gt;2.7; Bonferroni-corrected threshold of <italic>P</italic> &lt; .0125). Compared with participants without apathy, those with apathy had lower structural connectivity in the splenium, cingulum, and fronto-occipital fasciculus (<italic>t</italic> score &gt;2.5; false discovery rate–corrected <italic>P</italic> = .02). Twenty-seven participants completed escitalopram treatment; 16 (59%) achieved remission (HAM-D score &lt;10). Lower insula-DLPFC/midcingulate cortex rsFC was associated with less symptomatic improvement (HAM-D % change) (β [<italic>df</italic>] = 0.588 [26]; <italic>P</italic> = .001) and a higher likelihood of nonremission (odds ratio, 1.041 [95% CI, 1.003-1.081]; <italic>P</italic> = .04) after treatment and, in regression models, was a mediator of the association between baseline apathy and persistence of depression. Lower dorsal anterior cingulate-DLPFC/paracentral rsFC was associated with residual cognitive difficulties on measures of attention (β [<italic>df</italic>] = 0.445 [26]; <italic>P</italic> = .04) and executive function (β [<italic>df</italic>] = 0.384 [26]; <italic>P</italic> = .04).</p>
                </sec>
                <sec id="ab-zoi220679-10">
                  <title>Conclusions and Relevance</title>
                  <p>This study suggests that disturbances in connectivity between the salience network and other large-scale networks that support goal-directed behavior may give rise to apathy and may be associated with poor response of late-life depression to antidepressant pharmacotherapy. These network disturbances may serve as targets for novel interventions.</p>
                </sec>
                <sec id="ab-zoi220679-11">
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov Identifier: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT01728194" ext-link-type="uri">NCT01728194</ext-link></p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This secondary analysis of a nonrandomized clinical trial assesses the brain network features of apathy among individuals with late-life depression and identifies brain network abnormalities associated with poor antidepressant response.</p>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZOI220679">
              <title>Introduction</title>
              <p>Late-life depression (LLD) is a leading cause of disability<sup><xref rid="zoi220679r1" ref-type="bibr">1</xref></sup> and medical morbidity<sup><xref rid="zoi220679r2" ref-type="bibr">2</xref></sup> in older adulthood. One-third to one-half of patients with LLD also have apathy,<sup><xref rid="zoi220679r3" ref-type="bibr">3</xref></sup> a persistent and disabling syndrome of impaired motivation characterized by reduced goal-directed behavior, emotional blunting, and cognitive weaknesses.<sup><xref rid="zoi220679r4" ref-type="bibr">4</xref></sup> Apathy worsens clinical outcomes in LLD. Apathy results in social isolation, poor self-care, and sedentary behavior, with broad health consequences.<sup><xref rid="zoi220679r5" ref-type="bibr">5</xref>,<xref rid="zoi220679r6" ref-type="bibr">6</xref>,<xref rid="zoi220679r7" ref-type="bibr">7</xref>,<xref rid="zoi220679r8" ref-type="bibr">8</xref>,<xref rid="zoi220679r9" ref-type="bibr">9</xref>,<xref rid="zoi220679r10" ref-type="bibr">10</xref></sup> Relative to older adults with depression without apathy, those with comorbid apathy are far more likely to withdraw from medical care and have a more severe clinical course, higher caregiver burden, and functional decline.<sup><xref rid="zoi220679r6" ref-type="bibr">6</xref>,<xref rid="zoi220679r7" ref-type="bibr">7</xref></sup></p>
              <p>Remission rates of LLD are especially low among those with prominent apathy.<sup><xref rid="zoi220679r11" ref-type="bibr">11</xref></sup> Apathy is associated with poor response of depression to selective serotonin reuptake inhibitors (SSRIs), the first-line pharmacotherapy for LLD, and efficacious nonpharmacologic treatment alternatives for this patient population are scarce.<sup><xref rid="zoi220679r11" ref-type="bibr">11</xref>,<xref rid="zoi220679r12" ref-type="bibr">12</xref>,<xref rid="zoi220679r13" ref-type="bibr">13</xref>,<xref rid="zoi220679r14" ref-type="bibr">14</xref></sup> Despite the high prevalence and clinical impact of apathy among individuals with depression, little is known about its optimal treatment and, more broadly, about the brain-based mechanisms of apathy.</p>
              <p>An emerging hypothesis suggests that apathy and its impact on treatment response in LLD may reflect compromise of the salience network (SN) and its large-scale network connections.<sup><xref rid="zoi220679r5" ref-type="bibr">5</xref>,<xref rid="zoi220679r15" ref-type="bibr">15</xref>,<xref rid="zoi220679r16" ref-type="bibr">16</xref></sup> The SN, which includes the insula and dorsal anterior cingulate cortex (dACC), attributes motivational value to a stimulus. The SN dynamically coordinates the activity of other large-scale networks, including the executive control network and default mode network (DMN), to guide purposeful behavior.<sup><xref rid="zoi220679r17" ref-type="bibr">17</xref>,<xref rid="zoi220679r18" ref-type="bibr">18</xref></sup> The few magnetic resonance imaging (MRI) studies of apathy in depression report reduced volume in structures of the SN and preliminary evidence for disruption in functional connectivity among the SN, DMN, and executive control network.<sup><xref rid="zoi220679r3" ref-type="bibr">3</xref>,<xref rid="zoi220679r5" ref-type="bibr">5</xref>,<xref rid="zoi220679r19" ref-type="bibr">19</xref>,<xref rid="zoi220679r20" ref-type="bibr">20</xref></sup> Abnormalities within the SN may also predispose older adults with depression to poor response to traditional pharmacotherapies.<sup><xref rid="zoi220679r3" ref-type="bibr">3</xref></sup> However, the network mechanisms linking apathy to poor antidepressant response in LLD are not well understood.</p>
              <p>Identifying network abnormalities in apathy is crucial for understanding its behavioral manifestation in individuals with LLD and for developing new strategies of treatment in clinical practice. Connectometry is a novel approach to diffusion MRI analysis that quantifies the local connectome of white matter pathways.<sup><xref rid="zoi220679r21" ref-type="bibr">21</xref></sup> Connectometry is less susceptible to crossing fibers and partial volume effects and offers greater localization of microstructural abnormalities compared with conventional tract-based analysis<sup><xref rid="zoi220679r21" ref-type="bibr">21</xref>,<xref rid="zoi220679r22" ref-type="bibr">22</xref>,<xref rid="zoi220679r23" ref-type="bibr">23</xref>,<xref rid="zoi220679r24" ref-type="bibr">24</xref>,<xref rid="zoi220679r25" ref-type="bibr">25</xref></sup> but, to our knowledge, has not yet been applied to the study of apathy. Moreover, connectometry can be used alongside resting state imaging to identify network properties of apathy in major depression.</p>
              <p>Our primary objective was to evaluate functional connectivity and structural network disturbances associated with apathy in older adults with LLD. Informed by our conceptual framework, we focused on functional connectivity of the SN and hypothesized alterations in connectivity among key nodes of the SN and other core circuits that modulate goal-directed behavior (ie, DMN, executive control network) among individuals with depression and apathy. We further applied connectometry to identify pathway-level disruptions in structural connectivity and hypothesized that compromise of frontoparietal and frontolimbic pathways would be associated with apathy in LLD. Our secondary objective was to evaluate whether apathy-related network abnormalities were associated with antidepressant response after 12 weeks of pharmacotherapy with the SSRI escitalopram. Therefore, we assessed whether pretreatment variability in connectivity associated with apathy was associated with mood and cognitive outcomes after antidepressant treatment.</p>
            </sec>
            <sec id="H1-2-ZOI220679">
              <title>Methods</title>
              <sec id="H2-1-ZOI220679">
                <title>Participants</title>
                <p>The study, conducted at an outpatient geriatric psychiatry clinic from July 1, 2012, to July 31, 2019, included participants aged 59 to 85 years who met <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (Fourth Edition) (<italic>DSM-IV</italic>) criteria for major depressive disorder without psychotic features. Participants were recruited for a single-group, open-label escitalopram treatment trial (<ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT01728194" ext-link-type="uri">NCT01728194</ext-link>) through advertisements and clinical referrals. Participants provided written informed consent approved by the Weill Cornell Medicine and Nathan Kline Institute institutional review boards. Exclusion criteria were current or lifetime history of any Axis I psychiatric disorder other than major depressive disorder or comorbid generalized anxiety disorder, high suicide risk, history of electroconvulsive therapy, ongoing treatment with medications associated with depression (eMethods in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>), acute or severe medical illness, mild cognitive impairment or dementia, history of neurologic disease, and contraindications to undergoing MRI. The study and data are presented according to the Transparent Reporting of Evaluations With Nonrandomized Designs (<ext-link xlink:href="https://www.cdc.gov/trendstatement/" ext-link-type="uri">TREND</ext-link>) reporting guideline for nonrandomized clinical trials.<sup><xref rid="zoi220679r26" ref-type="bibr">26</xref></sup></p>
              </sec>
              <sec id="H2-2-ZOI220679">
                <title>Diagnostic Assessments</title>
                <p>A <italic>DSM-IV</italic> diagnosis was assigned by a study clinician based on the Structured Clinical Interview for <italic>DSM</italic>–Revised,<sup><xref rid="zoi220679r27" ref-type="bibr">27</xref></sup> and inclusion required a Hamilton Depression Rating Scale (HAM-D) score of 18 or more (range, 0-76, where 0 indicates no depression and 76 indicates severe depression).<sup><xref rid="zoi220679r28" ref-type="bibr">28</xref></sup> Mild cognitive impairment was assessed using the Petersen criteria<sup><xref rid="zoi220679r29" ref-type="bibr">29</xref></sup> and determined using a previously described classification procedure.<sup><xref rid="zoi220679r30" ref-type="bibr">30</xref></sup> Although the primary outcome for the main clinical trial was the Montgomery-Asberg Depression Rating Scale score, several items capture core features of apathy (Montgomery-Asberg Depression Rating Scale dysphoric apathy subscale).<sup><xref rid="zoi220679r31" ref-type="bibr">31</xref>,<xref rid="zoi220679r32" ref-type="bibr">32</xref></sup> Therefore, the HAM-D score was chosen as the primary depression outcome in the secondary analysis presented here.</p>
                <p>Apathy was evaluated using the clinician-rated version of the Apathy Evaluation Scale,<sup><xref rid="zoi220679r33" ref-type="bibr">33</xref>,<xref rid="zoi220679r34" ref-type="bibr">34</xref>,<xref rid="zoi220679r35" ref-type="bibr">35</xref></sup> a psychometrically validated instrument consisting of 18 items rated on a Likert scale.<sup><xref rid="zoi220679r33" ref-type="bibr">33</xref>,<xref rid="zoi220679r36" ref-type="bibr">36</xref>,<xref rid="zoi220679r37" ref-type="bibr">37</xref></sup> Total scores range from 18 to 72, with higher scores corresponding to more severe symptoms. An examination of the psychometric properties of the Apathy Evaluation Scale found that cutoff values greater than 40.5 and 37.5<sup><xref rid="zoi220679r33" ref-type="bibr">33</xref></sup> had similar sensitivity (88%), although a higher cutoff value had better specificity.<sup><xref rid="zoi220679r34" ref-type="bibr">34</xref></sup> Accordingly, an Apathy Evaluation Scale score of more than 40.5 was considered a priori to represent clinically significant apathy.<sup><xref rid="zoi220679r34" ref-type="bibr">34</xref>,<xref rid="zoi220679r35" ref-type="bibr">35</xref></sup></p>
              </sec>
              <sec id="H2-3-ZOI220679">
                <title>Neuropsychological Assessment</title>
                <p>A focused neuropsychological assessment conducted at baseline and after treatment included measures of processing speed, attention, memory, language, and executive functioning. This study focused on measures of attention (Digit Span Forward; Wechsler Adult Intelligence Scale, Fourth Edition) and executive function (Stroop Interference<sup><xref rid="zoi220679r38" ref-type="bibr">38</xref></sup> and Trail Making Test Part B − A) because they are commonly impaired among individuals with LLD and deficits often persist after antidepressant treatment.<sup><xref rid="zoi220679r39" ref-type="bibr">39</xref>,<xref rid="zoi220679r40" ref-type="bibr">40</xref></sup></p>
              </sec>
              <sec id="H2-4-ZOI220679">
                <title>Treatment Protocol</title>
                <p>Participants previously prescribed an antidepressant underwent a 2-week washout period under the care of a study psychiatrist. Those who remained eligible after the 2 weeks were treated with escitalopram for 12 weeks: 10 mg/d for 1 week, followed by an increase to the target dose of 20 mg/d. Participants unable to tolerate 20 mg/d received either 15 mg/d or 10 mg/d, which was the minimum study dose, for the remainder of their participation. Participants completed weekly assessments of depression and side effects<sup><xref rid="zoi220679r41" ref-type="bibr">41</xref></sup> with trained research assistants and a research psychiatrist (eMethods in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              </sec>
              <sec id="H2-5-ZOI220679">
                <title>Image Processing</title>
                <p>Structural T1, diffusion-weighted, and T2-weighted blood oxygen level–dependent functional imaging data were acquired on a 3T Siemens Tim Trio MRI scanner. Acquisition parameters have been previously reported<sup><xref rid="zoi220679r30" ref-type="bibr">30</xref>,<xref rid="zoi220679r38" ref-type="bibr">38</xref></sup> and are described along with preprocessing pipelines in the eMethods in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>.</p>
                <p>A hypothesis-driven seed-to-whole-brain approach was used to test for group differences in resting state functional connectivity (rsFC) of the SN between participants with depression and apathy and those with depression without apathy. The left and right insula and dACC—core SN hubs—were used as a priori seed regions generated from the Human Connectome Project–derived Glasser Parcellation Atlas.<sup><xref rid="zoi220679r42" ref-type="bibr">42</xref></sup> Individual rsFC maps for SN seeds were generated based on correlations between the mean signal time course within each seed region and each voxel of the brain. Group-level inferential models were conducted to compare the seed-based connectivity maps of participants with and without apathy. We implemented cluster-based inference using Gaussian random field theory with a height <italic>z</italic> score greater than 2.3<sup><xref rid="zoi220679r43" ref-type="bibr">43</xref>,<xref rid="zoi220679r44" ref-type="bibr">44</xref>,<xref rid="zoi220679r45" ref-type="bibr">45</xref>,<xref rid="zoi220679r46" ref-type="bibr">46</xref>,<xref rid="zoi220679r47" ref-type="bibr">47</xref>,<xref rid="zoi220679r48" ref-type="bibr">48</xref></sup> and a Bonferroni cluster correction of <italic>P</italic> &lt; .0125 (2-tailed) to account for the number of seeds analyzed (n = 4).</p>
                <p>Diffusion connectometry<sup><xref rid="zoi220679r21" ref-type="bibr">21</xref></sup> was applied to derive the correlational tractography showing an association between quantitative anisotropy and apathy.<sup><xref rid="zoi220679r49" ref-type="bibr">49</xref>,<xref rid="zoi220679r50" ref-type="bibr">50</xref></sup> Connectometry measures the degree of connectivity between adjacent voxels based on the density of diffusing spins and probes group differences within subcomponents of white matter pathways.<sup><xref rid="zoi220679r21" ref-type="bibr">21</xref></sup> The tensor metrics were calculated, and quantitative anisotropy was extracted as the local connectome fingerprint.<sup><xref rid="zoi220679r51" ref-type="bibr">51</xref></sup> A <italic>t</italic> score threshold of 2.5 was assigned and tracked using a deterministic fiber tracking algorithm,<sup><xref rid="zoi220679r52" ref-type="bibr">52</xref></sup> and connectometry was performed across the whole brain, excluding the cerebellum.<sup><xref rid="zoi220679r53" ref-type="bibr">53</xref>,<xref rid="zoi220679r54" ref-type="bibr">54</xref></sup> To estimate the false discovery rate (FDR), 10 000 randomized permutations were applied to the group label to obtain the null distribution of the track length. An FDR threshold of less than .05 was used to correct for multiple comparisons.<sup><xref rid="zoi220679r21" ref-type="bibr">21</xref>,<xref rid="zoi220679r52" ref-type="bibr">52</xref></sup></p>
              </sec>
              <sec id="H2-6-ZOI220679">
                <title>Statistical Analysis</title>
                <p>The <italic>t</italic> test, the Mann-Whitney test, and the χ<sup>2</sup> test were used to identify individual demographic and clinical variables that distinguished participants with depression without apathy from those with depression and apathy. β Weights and quantitative anisotropy values were extracted from significant clusters and fascicles that differed between groups in rsFC and connectometry analyses, respectively, to evaluate associations with clinical outcomes. Change in mood (HAM-D score) was the primary outcome, and change in attention and executive function served as secondary outcomes. Linear and logistic regression models were generated to evaluate whether group differences in baseline connectivity were associated with symptom change (percentage change in HAM-D score ) and remission of depression (HAM-D score &lt;10),<sup><xref rid="zoi220679r55" ref-type="bibr">55</xref></sup> adjusting for age and baseline depression severity. Secondary linear regression models assessed the associations between baseline connectivity and change in performance (posttreatment [T<sub>2</sub>] − baseline [T<sub>1</sub>]) on measures of attention (Digit Span Forward) and executive functioning (Trail Making Test Part B-A and Stroop Interference), adjusting for age, educational level, baseline depression severity (HAM-D score), and baseline task performance.</p>
                <p>In models with significant associations between baseline connectivity and treatment response, exploratory post hoc mediation analyses were performed<sup><xref rid="zoi220679r56" ref-type="bibr">56</xref></sup> to assess whether the association between presence of apathy and antidepressant response was mediated by apathy-associated abnormalities in connectivity. To estimate the indirect effect, bootstrapping (k = 5000 samples) was used to generate 95% CIs. Mediation results are considered significant if the 95% CI for the indirect path does not contain zero.<sup><xref rid="zoi220679r57" ref-type="bibr">57</xref></sup> Mediation models were fit in PROCESS, version 3.4.1<sup><xref rid="zoi220679r57" ref-type="bibr">57</xref></sup> for SPSS, version 26 (IBM SPSS).</p>
              </sec>
            </sec>
            <sec id="H1-3-ZOI220679">
              <title>Results</title>
              <sec id="H2-7-ZOI220679">
                <title>Sample Characteristics</title>
                <p>Forty older adults (26 women [65%]; mean [SD] age, 70.0 [6.6] years [range, 59-85 years]) with major depressive disorder were evaluated, of whom 20 had apathy at the prespecified threshold (Apathy Evaluation Scale score &gt;40.5). Groups did not differ significantly in age, sex, educational level, or baseline depression severity (<xref rid="zoi220679t1" ref-type="table">Table 1</xref>).</p>
                <table-wrap position="float" id="zoi220679t1">
                  <label>Table 1. </label>
                  <caption>
                    <title>Demographic and Clinical Characteristics of Patients</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="18.2%" span="1"/>
                    <col width="25.24%" span="1"/>
                    <col width="16.26%" span="1"/>
                    <col width="29.3%" span="1"/>
                    <col width="11%" span="1"/>
                    <thead>
                      <tr>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Total sample (N = 40)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">LLD (n = 20)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Apathy and LLD (n = 20)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD), y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">70.0 (6.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71.3 (6.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">68.8 (6.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.23</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">26 (65)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (70)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (60)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.74</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (35)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (40)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Educational level, mean (SD), y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14.9 (2.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14.9 (2.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14.9 (3.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.96</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">AES score</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mean (SD)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">39.9 (6.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">34.4 (3.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">45.6 (3.4)</td>
                        <td rowspan="2" valign="middle" align="left" colspan="1">&lt;.001</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Range</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">28-53</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">28-40</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">41-53</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">24-item HAM-D score, mean (SD)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">24.2 (3.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">23.2 (3.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">25.2 (4.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.11</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: AES, Apathy Evaluation Scale (clinician-rated version); HAM-D, Hamilton Depression Rating Scale; LLD, late-life depression.</p>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-8-ZOI220679">
                <title>Functional Connectivity of the SN in Apathy</title>
                <p>Compared with participants with depression alone, those with depression and apathy showed lower rsFC between the left insula seed and the right dorsolateral prefrontal cortex (DLPFC), midcingulate cortex (MCC), and premotor cortex (mean <italic>z</italic> score = 2.82; Bonferroni-corrected threshold of <italic>P</italic> &lt; .0125) (eTable in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>). Connectivity of the left insula with the left temporal pole and middle temporal gyrus was significantly greater in participants with apathy than those without apathy (mean <italic>z</italic> score = 2.78; Bonferroni-corrected threshold of <italic>P</italic> &lt; .0125) (<xref rid="zoi220679f1" ref-type="fig">Figure 1</xref>). Using the right insula seed, no significant group differences were observed.</p>
                <fig position="float" id="zoi220679f1" fig-type="figure">
                  <label>Figure 1. </label>
                  <caption>
                    <title>Differences in Functional Network Connectivity Associated With Apathy in Older Adults With Depression</title>
                    <p>Group differences in seed-to-whole-brain functional connectivity of the left insula. Blue indicates clusters with lower connectivity with the left insula seed in participants with depression and apathy compared with participants with depression alone. Yellow indicates clusters with higher connectivity with the left insula seed in participants with apathy and depression. Cluster-based inference was implemented using Gaussian random field theory with a Bonferroni cluster correction of <italic>P</italic> &lt; .0125 (2-tailed).</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2224142-g001" position="float"/>
                </fig>
                <p>Participants with depression and apathy showed lower rsFC between the right dACC seed and the right DLPFC, paracentral lobule (PCL), and anterior premotor cortex compared with participants with depression alone (mean <italic>z</italic> score = 3.0; Bonferroni-corrected threshold of <italic>P</italic> &lt; .0125) (eFigure 1 in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>). Participants with apathy also showed greater rsFC between the right dACC and the left lateral temporal cortex (mean <italic>z</italic> score = 2.72; Bonferroni-corrected threshold of <italic>P</italic> &lt; .0125). There were no group differences in connectivity using the left dACC seed.</p>
              </sec>
              <sec id="H2-9-ZOI220679">
                <title>Structural Connectivity in Apathy</title>
                <p>Connectometry analysis identified decreased structural connectivity (quantitative anisotropy) in the splenium of the corpus callosum, cingulum, and left inferior fronto-occipital fasciculus among participants with apathy compared with nonapathetic participants (<italic>t</italic> score &gt;2.5; FDR-corrected <italic>P</italic> = .02) (eFigure 2 in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>). There were no areas in which quantitative anisotropy was significantly higher among those with comorbid apathy.</p>
              </sec>
              <sec id="H2-10-ZOI220679">
                <title>Associations Between Baseline Connectivity and Antidepressant Response</title>
                <p>Twenty-seven participants completed the trial; 16 (59%) achieved remission (HAM-D score &lt;10). Adjusting for age and baseline depression severity, lower insula-DLPFC/MCC connectivity at baseline was associated with less reduction in depressive symptoms (percentage change in HAM-D score) (β [<italic>df</italic>] = 0.588 [26]; <italic>P</italic> = .001) (<xref rid="zoi220679t2" ref-type="table">Table 2</xref>) and a higher likelihood of nonremission (HAM-D score &lt;10) after treatment (odds ratio, 1.041 [95% CI, 1.003-1.081]; <italic>B</italic> [SE] = 0.04 [0.019]; <italic>P</italic> = .04) (<xref rid="zoi220679f2" ref-type="fig">Figure 2</xref>).</p>
                <table-wrap position="float" id="zoi220679t2">
                  <label>Table 2. </label>
                  <caption>
                    <title>Parameter Estimates From Linear Regression Models Assessing Associations Between Pretreatment Salience Network Connectivity and Antidepressant Treatment Response</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="38.59%" span="1"/>
                    <col width="40.06%" span="1"/>
                    <col width="10.85%" span="1"/>
                    <col width="10.5%" span="1"/>
                    <thead>
                      <tr>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Parameter</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Unstandardized <italic>B</italic> (95% CI)<xref rid="zoi220679t2n1" ref-type="table-fn"><sup>a</sup></xref></th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">β Value</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                          <bold>Insula-DLPFC/MCC connectivity</bold>
                        </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">HAM-D</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">48.3 (21.3 to 75.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.588</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.001</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">DSF</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">–0.02 (–2.21 to 2.16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.005</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.98</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Stroop Interference</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4.23 (–2.6 to 11.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.215</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.21</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Trail Making Test<xref rid="zoi220679t2n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.06 (–0.43 to 0.55)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.064</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.79</td>
                      </tr>
                      <tr>
                        <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                          <bold>dACC-DLPFC/PCL connectivity</bold>
                        </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">HAM-D</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">27.01 (–13.37 to 67.38)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.283</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.18</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">DSF</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.7 (0.12 to 5.20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.445</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.04</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Stroop Interference</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8.8 (0.52 to 17.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.384</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.04</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Trail Making Test<xref rid="zoi220679t2n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">–0.34 (–0.90 to 0.22)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">–0.330</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">.22</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: dACC, dorsal anterior cingulate cortex; DLPFC, dorsolateral prefrontal cortex; DSF, Digit Span Forward; HAM-D, Hamilton Depression Rating Scale; MCC, midcingulate cortex; PCL, paracentral lobule.</p>
                    <fn id="zoi220679t2n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>HAM-D, DSF, and Stroop Interference regression model <italic>df</italic> = 26. The HAM-D reflects the percentage change in HAM-D score from baseline to posttreatment.</p>
                    </fn>
                    <fn id="zoi220679t2n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Trail Making Test regression model <italic>df</italic> = 21. The Trail Making Test reflects the change in difference in duration between Part A and Part B (B − A) from baseline to posttreatment.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig position="float" id="zoi220679f2" fig-type="figure">
                  <label>Figure 2. </label>
                  <caption>
                    <title>Associations Between Baseline Functional Connectivity and Antidepressant Treatment Response</title>
                    <p>A, Lower pretreatment insula–dorsolateral prefrontal cortex (DLPFC)/midcingulate cortex (MCC) connectivity, which was associated with presence of apathy at baseline, was associated with greater persistence of depression (lower percentage change in Hamilton Depression Rating Scale [HAM-D] score) after treatment (β = 0.588; Δ<italic>R</italic><sup>2</sup> = 0.34). The <italic>R</italic><sup>2</sup> value indicates the change in variance that is explained (Δ<italic>R</italic><sup>2</sup>) when functional connectivity is added to the regression model adjusted for age and baseline depression severity (HAM-D score). The shaded area indicates SE. B, Lower insula-DLPFC/MCC connectivity at baseline was associated with a higher likelihood of nonremission of depression (HAM-D score &lt;10) after treatment (odds ratio, 1.041 [95% CI, 1.003-1.081]; <italic>P</italic> = .04). The box plot depicts insula-DLPFC/MCC connectivity of participants who did not achieve remission and participants who achieved remission. The median is denoted by the line within the box; 25th percentile, bottom border of box; 75th percentile, top border of box; variability outside the IQR, whiskers; and outside values, dots.</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2224142-g002" position="float"/>
                </fig>
                <p>There was no significant association between dACC connectivity and change in HAM-D score. However, there were positive associations between dACC-DLPFC/PCL connectivity and change in cognitive performance. Specifically, lower baseline dACC-DLPFC/PCL connectivity was associated with less improvement (stable or reduced performance) on measures of attention (β [<italic>df</italic>] = 0.445 [26]; <italic>P</italic> = .04) and executive function (β [<italic>df</italic>] = 0.384 [26]; <italic>P</italic> = .04) (Stroop Interference), while greater connectivity was associated with greater improvement in performance after treatment (eFigure 3 in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref>). Baseline group differences in structural connectivity were not significantly associated with mood or cognitive outcomes.</p>
                <p>Exploratory post hoc mediation analysis showed that the presence of apathy at baseline was associated with a poorer antidepressant response (lower percentage change in HAM-D score) after treatment (c path; β = <italic>–</italic>0.933; <italic>P</italic> = .02). There was an association between apathy and insula-DLPFC/MCC connectivity (a path; β = –1.20; <italic>P</italic> = .002), which was expected as connectivity was defined by its association with apathy in the baseline sample. There was also a significant indirect effect of insula connectivity, suggesting that group differences in insula-DLPFC/MCC connectivity mediated the association between apathy and treatment response (indirect effect β = –0.586; bootstrapped 95% CI, –1.477 to –0.072). Path coefficients indicate that baseline apathy was associated with lower insula-DLPFC/MCC connectivity which, in turn, was associated with poorer antidepressant response (see the eResults in <xref rid="note-ZOI220679-1-s" ref-type="supplementary-material">Supplement 1</xref> for post hoc sensitivity analyses).</p>
              </sec>
            </sec>
            <sec id="H1-4-ZOI220679">
              <title>Discussion</title>
              <p>The principal finding of this study is that, relative to participants with depression alone, those with depression and apathy showed alterations in rsFC between the SN and large-scale networks that support goal-directed behavior (DMN and executive control network) and compromised structural connectivity in a core set of brain circuits. Moreover, apathy-related alterations in rsFC were associated with reduced symptomatic improvement and a lower likelihood of remission of depression, as well as persistent cognitive dysfunction, after 12 weeks of treatment with escitalopram.</p>
              <p>These findings support an emerging model of apathy, which proposes that apathy may arise from dysfunctional interactions among core networks (ie, SN, DMN, and executive control) that support motivated behavior.<sup><xref rid="zoi220679r58" ref-type="bibr">58</xref>,<xref rid="zoi220679r59" ref-type="bibr">59</xref>,<xref rid="zoi220679r60" ref-type="bibr">60</xref></sup> Evidence for this model has been derived largely from studies of neurodegenerative disorders and stroke,<sup><xref rid="zoi220679r12" ref-type="bibr">12</xref>,<xref rid="zoi220679r14" ref-type="bibr">14</xref>,<xref rid="zoi220679r61" ref-type="bibr">61</xref></sup> leaving the mechanisms underlying motivational disturbances among individuals with depression poorly understood.</p>
              <p>In a sample of older adults with LLD, those with comorbid apathy showed reduced rsFC between the SN and the DLPFC, a key node of the executive control network, as well as the premotor cortex and PCL. The SN communicates with the executive control network to mobilize the cognitive resources required for goal-directed behavior<sup><xref rid="zoi220679r58" ref-type="bibr">58</xref>,<xref rid="zoi220679r62" ref-type="bibr">62</xref></sup> and sends signals to primary and secondary motor cortices to facilitate action initiation.<sup><xref rid="zoi220679r63" ref-type="bibr">63</xref>,<xref rid="zoi220679r64" ref-type="bibr">64</xref></sup> Functional disconnection between the SN and DLPFC may indicate reduced synchrony of systems supporting attentional control, working memory, and cognitive flexibility–core processes disrupted in apathy.<sup><xref rid="zoi220679r8" ref-type="bibr">8</xref>,<xref rid="zoi220679r60" ref-type="bibr">60</xref>,<xref rid="zoi220679r65" ref-type="bibr">65</xref></sup> Moreover, altered communication between the SN and motor systems may result in difficulties translating intention into action.<sup><xref rid="zoi220679r66" ref-type="bibr">66</xref></sup> These observations converge with reports in healthy adults showing associations between disturbances in rsFC between the SN and executive control network and reduced motivation,<sup><xref rid="zoi220679r67" ref-type="bibr">67</xref>,<xref rid="zoi220679r68" ref-type="bibr">68</xref></sup> as well as work linking lower rsFC between the dACC and supplementary motor area to apathy among community-dwelling adults.<sup><xref rid="zoi220679r66" ref-type="bibr">66</xref></sup></p>
              <p>Participants with apathy and depression also showed higher rsFC between SN seeds and the dorsal medial subsystem of the DMN. In response to salient stimuli, the SN generates control signals that downregulate the DMN in favor of task-positive networks, such as the executive control network.<sup><xref rid="zoi220679r17" ref-type="bibr">17</xref>,<xref rid="zoi220679r18" ref-type="bibr">18</xref></sup> Increased rsFC with the SN may reflect difficulty modulating or disengaging the DMN, affecting the ability to generate cognitive strategies necessary for motivated behavior while ignoring irrelevant or internally directed stimuli. Consistent with this model, failure to suppress the DMN is associated with lapses in attention and decreased cognitive control performance,<sup><xref rid="zoi220679r69" ref-type="bibr">69</xref></sup> core features associated with apathy.<sup><xref rid="zoi220679r8" ref-type="bibr">8</xref>,<xref rid="zoi220679r70" ref-type="bibr">70</xref></sup> These findings also align with a prior preliminary study showing increased rsFC between the insula and nodes of the DMN among participants with depression and apathy relative to healthy older adults.<sup><xref rid="zoi220679r5" ref-type="bibr">5</xref></sup></p>
              <p>Along with functional network abnormalities, we applied diffusion connectometry to evaluate pathway-level disruptions in structural connectivity associated with apathy.<sup><xref rid="zoi220679r21" ref-type="bibr">21</xref></sup> Participants with comorbid apathy showed lower structural connectivity in the splenium, left inferior fronto-occipital fasciculus, and cingulum than those without apathy. The cingulum enables communication between the cingulate cortex, parietal, and medial temporal regions,<sup><xref rid="zoi220679r71" ref-type="bibr">71</xref></sup> and integrity of this pathway has been associated with processes disrupted in apathy,<sup><xref rid="zoi220679r72" ref-type="bibr">72</xref></sup> including affective processing, decision-making, and behavioral initiation.<sup><xref rid="zoi220679r14" ref-type="bibr">14</xref>,<xref rid="zoi220679r60" ref-type="bibr">60</xref>,<xref rid="zoi220679r69" ref-type="bibr">69</xref></sup> The fronto-occipital fasciculus connects frontal, insular, occipital, and parietal regions,<sup><xref rid="zoi220679r73" ref-type="bibr">73</xref>,<xref rid="zoi220679r74" ref-type="bibr">74</xref></sup> and the splenium is a commissural tract that connects the posterior parietal, temporal, and occipital cortices. Efficient transmission of sensory information to the SN is needed to identify salient stimuli and guide goal-directed behavior.<sup><xref rid="zoi220679r17" ref-type="bibr">17</xref>,<xref rid="zoi220679r62" ref-type="bibr">62</xref></sup> Microstructural abnormalities in these pathways may reduce interhemispheric communication and the integration of sensory signals with frontal and insular structures.<sup><xref rid="zoi220679r73" ref-type="bibr">73</xref></sup> Thus, along with frontolimbic fibers, compromise of pathways that facilitate the transmission of sensory signals for salience processing may be associated with the apathy trait.</p>
              <p>More broadly, these findings collectively suggest that apathy among individuals with LLD may be associated with disturbances in SN modulation of large-scale circuits (DMN and executive control network) to facilitate goal-directed behavior. This may cause a failure of network integration,<sup><xref rid="zoi220679r17" ref-type="bibr">17</xref>,<xref rid="zoi220679r18" ref-type="bibr">18</xref></sup> leading to difficulties with salience processing, action planning, and behavioral initiation that manifests clinically as apathy.</p>
              <p>Select circuit abnormalities associated with apathy at baseline were also associated with individual differences in response to an SSRI treatment trial. Specifically, low pretreatment insula-DLPFC/MCC connectivity was associated with reduced response and remission of depression, while low dACC-DLPFC/PCL connectivity was associated with residual cognitive difficulties on measures of attention and executive function. In exploratory analyses, lower insula-DLPFC/MCC connectivity mediated the association between presence of apathy and poor antidepressant response. Thus, apathy-related variability in rsFC may predispose older adults with depression to persistent mood and cognitive deficits after traditional antidepressant pharmacotherapy. These data suggest that the effectiveness of SSRI treatment in LLD may rely on an intact ability to detect and transmit signals of salience, and highlight SN-executive control network connectivity as a potential therapeutic target for novel interventions.</p>
              <sec id="H2-11-ZOI220679">
                <title>Limitations</title>
                <p>This study has several limitations. There was no longitudinal follow-up after acute treatment and a relatively limited neuropsychological battery, so we cannot establish the persistence of treatment differences nor the specificity of cognitive associations. Although we attempted to exclude participants with mild cognitive impairment, it is possible that some participants may have had mild cognitive impairment that was not detected by our evaluation process. In addition, the study sample size is relatively small and was reduced at follow-up. As such, the longitudinal findings, including the post hoc mediation analyses, should be considered preliminary. Follow-up studies with larger samples using multiple cognitive measures and a more comprehensive diagnostic assessment of apathy<sup><xref rid="zoi220679r4" ref-type="bibr">4</xref></sup> will increase confidence in our results. There are also opportunities to optimize our imaging approach. The functional MRI scan was relatively short based on current standards, and a longer multiband acquisition would improve the precision of signal estimation. For cluster-based analyses, we applied a threshold commonly used in clinical trials and studies with modest sample sizes,<sup><xref rid="zoi220679r43" ref-type="bibr">43</xref>,<xref rid="zoi220679r44" ref-type="bibr">44</xref>,<xref rid="zoi220679r45" ref-type="bibr">45</xref>,<xref rid="zoi220679r46" ref-type="bibr">46</xref>,<xref rid="zoi220679r47" ref-type="bibr">47</xref>,<xref rid="zoi220679r48" ref-type="bibr">48</xref></sup> although a more conservative threshold would further reduce the risk of type I error. We applied a hypothesis-driven, seed-to-whole-brain rsFC approach focused on the SN. Future studies evaluating other networks that may be disrupted in apathy, including the reward network,<sup><xref rid="zoi220679r16" ref-type="bibr">16</xref>,<xref rid="zoi220679r58" ref-type="bibr">58</xref></sup> will provide further insights into its etiopathogenesis.</p>
              </sec>
            </sec>
            <sec id="H1-5-ZOI220679">
              <title>Conclusions</title>
              <p>This secondary analysis of a nonrandomized clinical trial suggests that disturbances in connectivity among a core set of brain networks that support motivated behavior (SN, DMN, and executive control network) may give rise to apathy and predispose depressed older adults to poor response to first-line pharmacotherapies. These findings contribute to our understanding of the functional neuroanatomy of motivational disturbances in depression and the network pathways linking apathy to poor clinical outcomes in LLD. Novel interventions that modulate interactions among affected circuits may help to improve clinical outcomes in this distinct subgroup of older adults with depression, for whom few effective treatments exist.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZOI220679">
              <title>References</title>
              <ref id="zoi220679r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ormel</surname><given-names>J</given-names></string-name>, <string-name><surname>Rijsdijk</surname><given-names>FV</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>M</given-names></string-name>, <string-name><surname>van Sonderen</surname><given-names>E</given-names></string-name>, <string-name><surname>Kempen</surname><given-names>GI</given-names></string-name></person-group>. <article-title>Temporal and reciprocal relationship between IADL/ADL disability and depressive symptoms in late life</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source>. <year>2002</year>;<volume>57</volume>(<issue>4</issue>):<fpage>338</fpage>-<lpage>347</lpage>. doi:<pub-id pub-id-type="doi">10.1093/geronb/57.4.P338</pub-id><?supplied-pmid 12084784?><pub-id pub-id-type="pmid">12084784</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Katon</surname><given-names>W</given-names></string-name>, <string-name><surname>Lin</surname><given-names>EHB</given-names></string-name>, <string-name><surname>Kroenke</surname><given-names>K</given-names></string-name></person-group>. <article-title>The association of depression and anxiety with medical symptom burden in patients with chronic medical illness</article-title>. <source>Gen Hosp Psychiatry</source>. <year>2007</year>;<volume>29</volume>(<issue>2</issue>):<fpage>147</fpage>-<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2006.11.005</pub-id><?supplied-pmid 17336664?><pub-id pub-id-type="pmid">17336664</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pimontel</surname><given-names>MA</given-names></string-name>, <string-name><surname>Solomonov</surname><given-names>N</given-names></string-name>, <string-name><surname>Oberlin</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Cortical thickness of the salience network and change in apathy following antidepressant treatment for late-life depression</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2021</year>;<volume>29</volume>(<issue>3</issue>):<fpage>241</fpage>-<lpage>248</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jagp.2020.06.007</pub-id><?supplied-pmid 32680763?><pub-id pub-id-type="pmid">32680763</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Robert</surname><given-names>P</given-names></string-name>, <string-name><surname>Lanctôt</surname><given-names>KL</given-names></string-name>, <string-name><surname>Agüera-Ortiz</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Is it time to revise the diagnostic criteria for apathy in brain disorders? the 2018 international consensus group</article-title>. <source>Eur Psychiatry</source>. <year>2018</year>;<volume>54</volume>:<fpage>71</fpage>-<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eurpsy.2018.07.008</pub-id><?supplied-pmid 30125783?><pub-id pub-id-type="pmid">30125783</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yuen</surname><given-names>GS</given-names></string-name>, <string-name><surname>Gunning-Dixon</surname><given-names>FM</given-names></string-name>, <string-name><surname>Hoptman</surname><given-names>MJ</given-names></string-name>, <etal/></person-group>. <article-title>The salience network in the apathy of late-life depression</article-title>. <source>Int J Geriatr Psychiatry</source>. <year>2014</year>;<volume>29</volume>(<issue>11</issue>):<fpage>1116</fpage>-<lpage>1124</lpage>. doi:<pub-id pub-id-type="doi">10.1002/gps.4171</pub-id><?supplied-pmid 24990625?><pub-id pub-id-type="pmid">24990625</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ayers</surname><given-names>E</given-names></string-name>, <string-name><surname>Shapiro</surname><given-names>M</given-names></string-name>, <string-name><surname>Holtzer</surname><given-names>R</given-names></string-name>, <string-name><surname>Barzilai</surname><given-names>N</given-names></string-name>, <string-name><surname>Milman</surname><given-names>S</given-names></string-name>, <string-name><surname>Verghese</surname><given-names>J</given-names></string-name></person-group>. <article-title>Symptoms of apathy independently predict incident frailty and disability in community-dwelling older adults</article-title>. <source>J Clin Psychiatry</source>. <year>2017</year>;<volume>78</volume>(<issue>5</issue>):<fpage>e529</fpage>-<lpage>e536</lpage>. doi:<pub-id pub-id-type="doi">10.4088/JCP.15m10113</pub-id><?supplied-pmid 28406265?><pub-id pub-id-type="pmid">28406265</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yuen</surname><given-names>GS</given-names></string-name>, <string-name><surname>Bhutani</surname><given-names>S</given-names></string-name>, <string-name><surname>Lucas</surname><given-names>BJ</given-names></string-name>, <etal/></person-group>. <article-title>Apathy in late-life depression: common, persistent, and disabling</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2015</year>;<volume>23</volume>(<issue>5</issue>):<fpage>488</fpage>-<lpage>494</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jagp.2014.06.005</pub-id><?supplied-pmid 25047306?><pub-id pub-id-type="pmid">25047306</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Funes</surname><given-names>CM</given-names></string-name>, <string-name><surname>Lavretsky</surname><given-names>H</given-names></string-name>, <string-name><surname>Ercoli</surname><given-names>L</given-names></string-name>, <string-name><surname>St Cyr</surname><given-names>N</given-names></string-name>, <string-name><surname>Siddarth</surname><given-names>P</given-names></string-name></person-group>. <article-title>Apathy mediates cognitive difficulties in geriatric depression</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2018</year>;<volume>26</volume>(<issue>1</issue>):<fpage>100</fpage>-<lpage>106</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jagp.2017.06.012</pub-id><?supplied-pmid 28755989?><pub-id pub-id-type="pmid">28755989</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name><surname>Smith</surname><given-names>EE</given-names></string-name>, <string-name><surname>Geda</surname><given-names>Y</given-names></string-name>, <etal/>; <collab>ISTAART Neuropsychiatric Symptoms Professional Interest Area</collab></person-group>. <article-title>Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment</article-title>. <source>Alzheimers Dement</source>. <year>2016</year>;<volume>12</volume>(<issue>2</issue>):<fpage>195</fpage>-<lpage>202</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jalz.2015.05.017</pub-id><?supplied-pmid 26096665?><pub-id pub-id-type="pmid">26096665</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ceïde</surname><given-names>ME</given-names></string-name>, <string-name><surname>Warhit</surname><given-names>A</given-names></string-name>, <string-name><surname>Ayers</surname><given-names>EI</given-names></string-name>, <string-name><surname>Kennedy</surname><given-names>G</given-names></string-name>, <string-name><surname>Verghese</surname><given-names>J</given-names></string-name></person-group>. <article-title>Apathy and the risk of predementia syndromes in community-dwelling older adults</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source>. <year>2020</year>;<volume>75</volume>(<issue>7</issue>):<fpage>1443</fpage>-<lpage>1450</lpage>. doi:<pub-id pub-id-type="doi">10.1093/geronb/gbaa063</pub-id><?supplied-pmid 32374839?><pub-id pub-id-type="pmid">32374839</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Barnhart</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Makela</surname><given-names>EH</given-names></string-name>, <string-name><surname>Latocha</surname><given-names>MJ</given-names></string-name></person-group>. <article-title>SSRI-induced apathy syndrome: a clinical review</article-title>. <source>J Psychiatr Pract</source>. <year>2004</year>;<volume>10</volume>(<issue>3</issue>):<fpage>196</fpage>-<lpage>199</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00131746-200405000-00010</pub-id><?supplied-pmid 15330228?><pub-id pub-id-type="pmid">15330228</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pimontel</surname><given-names>MA</given-names></string-name>, <string-name><surname>Kanellopoulos</surname><given-names>D</given-names></string-name>, <string-name><surname>Gunning</surname><given-names>FM</given-names></string-name></person-group>. <article-title>Neuroanatomical abnormalities in older depressed adults with apathy: a systematic review</article-title>. <source>J Geriatr Psychiatry Neurol</source>. <year>2020</year>;<volume>33</volume>(<issue>5</issue>):<fpage>289</fpage>-<lpage>303</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0891988719882100</pub-id><?supplied-pmid 31635522?><pub-id pub-id-type="pmid">31635522</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Leontjevas</surname><given-names>R</given-names></string-name>, <string-name><surname>Teerenstra</surname><given-names>S</given-names></string-name>, <string-name><surname>Smalbrugge</surname><given-names>M</given-names></string-name>, <etal/></person-group>. More insight into the concept of apathy: a multidisciplinary depression management program has different effects on depressive symptoms and apathy in nursing homes. <source>Int Psychogeriatr</source>. <year>2013</year>;25(12):1941-1952. doi:<pub-id pub-id-type="doi">10.1017/S1041610213001440</pub-id><?supplied-pmid 23992241?><pub-id pub-id-type="pmid">23992241</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lanctôt</surname><given-names>KL</given-names></string-name>, <string-name><surname>Agüera-Ortiz</surname><given-names>L</given-names></string-name>, <string-name><surname>Brodaty</surname><given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Apathy associated with neurocognitive disorders: recent progress and future directions</article-title>. <source>Alzheimers Dement</source>. <year>2017</year>;<volume>13</volume>(<issue>1</issue>):<fpage>84</fpage>-<lpage>100</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jalz.2016.05.008</pub-id><?supplied-pmid 27362291?><pub-id pub-id-type="pmid">27362291</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gunning</surname><given-names>FM</given-names></string-name>, <string-name><surname>Oberlin</surname><given-names>LE</given-names></string-name>, <string-name><surname>Schier</surname><given-names>M</given-names></string-name>, <string-name><surname>Victoria</surname><given-names>LW</given-names></string-name></person-group>. <article-title>Brain-based mechanisms of late-life depression: implications for novel interventions</article-title>. <source>Semin Cell Dev Biol</source>. <year>2021</year>;<volume>116</volume>(<issue>1</issue>):<fpage>169</fpage>-<lpage>179</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.semcdb.2021.05.002</pub-id><?supplied-pmid 33992530?><pub-id pub-id-type="pmid">33992530</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Taylor</surname><given-names>WD</given-names></string-name>, <string-name><surname>Zald</surname><given-names>DH</given-names></string-name>, <string-name><surname>Felger</surname><given-names>JC</given-names></string-name>, <etal/></person-group>. <article-title>Influences of dopaminergic system dysfunction on late-life depression</article-title>. <source>Mol Psychiatry</source>. <year>2022</year>;<volume>27</volume>(<issue>1</issue>):<fpage>180</fpage>-<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41380-021-01265-0</pub-id><?supplied-pmid 34404915?><pub-id pub-id-type="pmid">34404915</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Uddin</surname><given-names>LQ</given-names></string-name></person-group>. <article-title>Salience processing and insular cortical function and dysfunction</article-title>. <source>Nat Rev Neurosci</source>. <year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>55</fpage>-<lpage>61</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn3857</pub-id><?supplied-pmid 25406711?><pub-id pub-id-type="pmid">25406711</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sridharan</surname><given-names>D</given-names></string-name>, <string-name><surname>Levitin</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Menon</surname><given-names>V</given-names></string-name></person-group>. <article-title>A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>(<issue>34</issue>):<fpage>12569</fpage>-<lpage>12574</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0800005105</pub-id><?supplied-pmid 18723676?><pub-id pub-id-type="pmid">18723676</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lavretsky</surname><given-names>H</given-names></string-name>, <string-name><surname>Ballmaier</surname><given-names>M</given-names></string-name>, <string-name><surname>Pham</surname><given-names>D</given-names></string-name>, <string-name><surname>Toga</surname><given-names>A</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>A</given-names></string-name></person-group>. <article-title>Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2007</year>;<volume>15</volume>(<issue>5</issue>):<fpage>386</fpage>-<lpage>394</lpage>. doi:<pub-id pub-id-type="doi">10.1097/JGP.0b013e3180325a16</pub-id><?supplied-pmid 17463189?><pub-id pub-id-type="pmid">17463189</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Alexopoulos</surname><given-names>GS</given-names></string-name>, <string-name><surname>Hoptman</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Yuen</surname><given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>Functional connectivity in apathy of late-life depression: a preliminary study</article-title>. <source>J Affect Disord</source>. <year>2013</year>;<volume>149</volume>(<issue>1-3</issue>):<fpage>398</fpage>-<lpage>405</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2012.11.023</pub-id><?supplied-pmid 23261142?><pub-id pub-id-type="pmid">23261142</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Badre</surname><given-names>D</given-names></string-name>, <string-name><surname>Verstynen</surname><given-names>T</given-names></string-name></person-group>. <article-title>Connectometry: a statistical approach harnessing the analytical potential of the local connectome</article-title>. <source>Neuroimage</source>. <year>2016</year>;<volume>125</volume>:<fpage>162</fpage>-<lpage>171</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.10.053</pub-id><?supplied-pmid 26499808?><pub-id pub-id-type="pmid">26499808</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sihvonen</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Virtala</surname><given-names>P</given-names></string-name>, <string-name><surname>Thiede</surname><given-names>A</given-names></string-name>, <string-name><surname>Laasonen</surname><given-names>M</given-names></string-name>, <string-name><surname>Kujala</surname><given-names>T</given-names></string-name></person-group>. <article-title>Structural white matter connectometry of reading and dyslexia</article-title>. <source>Neuroimage</source>. <year>2021</year>;<volume>241</volume>:<elocation-id>118411</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2021.118411</pub-id><?supplied-pmid 34293464?><pub-id pub-id-type="pmid">34293464</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sobhani</surname><given-names>S</given-names></string-name>, <string-name><surname>Rahmani</surname><given-names>F</given-names></string-name>, <string-name><surname>Aarabi</surname><given-names>MH</given-names></string-name>, <string-name><surname>Sadr</surname><given-names>AV</given-names></string-name></person-group>. <article-title>Exploring white matter microstructure and olfaction dysfunction in early Parkinson disease: diffusion MRI reveals new insight</article-title>. <source>Brain Imaging Behav</source>. <year>2019</year>;<volume>13</volume>(<issue>1</issue>):<fpage>210</fpage>-<lpage>219</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11682-017-9781-0</pub-id><?supplied-pmid 29134611?><pub-id pub-id-type="pmid">29134611</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ansari</surname><given-names>M</given-names></string-name>, <string-name><surname>Rahmani</surname><given-names>F</given-names></string-name>, <string-name><surname>Dolatshahi</surname><given-names>M</given-names></string-name>, <string-name><surname>Pooyan</surname><given-names>A</given-names></string-name>, <string-name><surname>Aarabi</surname><given-names>MH</given-names></string-name></person-group>. <article-title>Brain pathway differences between Parkinson’s disease patients with and without REM sleep behavior disorder</article-title>. <source>Sleep Breath</source>. <year>2017</year>;<volume>21</volume>(<issue>1</issue>):<fpage>155</fpage>-<lpage>161</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-016-1435-8</pub-id><?supplied-pmid 27853964?><pub-id pub-id-type="pmid">27853964</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sanjari Moghaddam</surname><given-names>H</given-names></string-name>, <string-name><surname>Dolatshahi</surname><given-names>M</given-names></string-name>, <string-name><surname>Salardini</surname><given-names>E</given-names></string-name>, <string-name><surname>Aarabi</surname><given-names>MH</given-names></string-name></person-group>. <article-title>Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease</article-title>. <source>Neurol Sci</source>. <year>2019</year>;<volume>40</volume>(<issue>2</issue>):<fpage>283</fpage>-<lpage>291</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10072-018-3629-2</pub-id><?supplied-pmid 30386933?><pub-id pub-id-type="pmid">30386933</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Des Jarlais</surname><given-names>DC</given-names></string-name>, <string-name><surname>Lyles</surname><given-names>C</given-names></string-name>, <string-name><surname>Crepaz</surname><given-names>N</given-names></string-name>; <collab>TREND Group</collab></person-group>. <article-title>Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement</article-title>. <source>Am J Public Health</source>. <year>2004</year>;<volume>94</volume>(<issue>3</issue>):<fpage>361</fpage>-<lpage>366</lpage>. doi:<pub-id pub-id-type="doi">10.2105/AJPH.94.3.361</pub-id><?supplied-pmid 14998794?><pub-id pub-id-type="pmid">14998794</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r27">
                <label>27</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>First</surname><given-names>MB</given-names></string-name>, <string-name><surname>Gibbon</surname><given-names>M</given-names></string-name></person-group>. <part-title>The Structured Clinical Interview for <italic>DSM-IV</italic> Axis I Disorders (SCID-I) and the Structured Clinical Interview for <italic>DSM-IV</italic> Axis II Disorders (SCID-II)</part-title>. In: Hilsenroth MJ, Segal DL, eds. <italic>Comprehensive Handbook of Psychological Assessment. Vol 2: Personality Assessment</italic>. John Wiley &amp; Sons Inc; 2004:134-143.</mixed-citation>
              </ref>
              <ref id="zoi220679r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Williams</surname><given-names>JBW</given-names></string-name></person-group>. <article-title>A structured interview guide for the Hamilton Depression Rating Scale</article-title>. <source>Arch Gen Psychiatry</source>. <year>1988</year>;<volume>45</volume>(<issue>8</issue>):<fpage>742</fpage>-<lpage>747</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.1988.01800320058007</pub-id><?supplied-pmid 3395203?><pub-id pub-id-type="pmid">3395203</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Petersen</surname><given-names>RC</given-names></string-name></person-group>. <article-title>Mild cognitive impairment as a diagnostic entity</article-title>. <source>J Intern Med</source>. <year>2004</year>;<volume>256</volume>(<issue>3</issue>):<fpage>183</fpage>-<lpage>194</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2796.2004.01388.x</pub-id><?supplied-pmid 15324362?><pub-id pub-id-type="pmid">15324362</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Oberlin</surname><given-names>LE</given-names></string-name>, <string-name><surname>Respino</surname><given-names>M</given-names></string-name>, <string-name><surname>Victoria</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease</article-title>. <source>Neuropsychopharmacology</source>. <year>2022</year>;<volume>47</volume>(<issue>2</issue>):<fpage>580</fpage>-<lpage>587</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41386-021-00973-z</pub-id><?supplied-pmid 33564103?><pub-id pub-id-type="pmid">33564103</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sockeel</surname><given-names>P</given-names></string-name>, <string-name><surname>Dujardin</surname><given-names>K</given-names></string-name>, <string-name><surname>Devos</surname><given-names>D</given-names></string-name>, <string-name><surname>Denève</surname><given-names>C</given-names></string-name>, <string-name><surname>Destée</surname><given-names>A</given-names></string-name>, <string-name><surname>Defebvre</surname><given-names>L</given-names></string-name></person-group>. <article-title>The Lille Apathy Rating Scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2006</year>;<volume>77</volume>(<issue>5</issue>):<fpage>579</fpage>-<lpage>584</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.2005.075929</pub-id><?supplied-pmid 16614016?><pub-id pub-id-type="pmid">16614016</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Parker</surname><given-names>RD</given-names></string-name>, <string-name><surname>Flint</surname><given-names>EP</given-names></string-name>, <string-name><surname>Bosworth</surname><given-names>HB</given-names></string-name>, <string-name><surname>Pieper</surname><given-names>CF</given-names></string-name>, <string-name><surname>Steffens</surname><given-names>DC</given-names></string-name></person-group>. <article-title>A three-factor analytic model of the MADRS in geriatric depression</article-title>. <source>Int J Geriatr Psychiatry</source>. <year>2003</year>;<volume>18</volume>(<issue>1</issue>):<fpage>73</fpage>-<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1002/gps.776</pub-id><?supplied-pmid 12497559?><pub-id pub-id-type="pmid">12497559</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Marin</surname><given-names>RS</given-names></string-name>, <string-name><surname>Biedrzycki</surname><given-names>RC</given-names></string-name>, <string-name><surname>Firinciogullari</surname><given-names>S</given-names></string-name></person-group>. <article-title>Reliability and validity of the Apathy Evaluation Scale</article-title>. <source>Psychiatry Res</source>. <year>1991</year>;<volume>38</volume>(<issue>2</issue>):<fpage>143</fpage>-<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-1781(91)90040-V</pub-id><?supplied-pmid 1754629?><pub-id pub-id-type="pmid">1754629</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Clarke</surname><given-names>DE</given-names></string-name>, <string-name><surname>van Reekum</surname><given-names>R</given-names></string-name>, <string-name><surname>Simard</surname><given-names>M</given-names></string-name>, <string-name><surname>Streiner</surname><given-names>DL</given-names></string-name>, <string-name><surname>Freedman</surname><given-names>M</given-names></string-name>, <string-name><surname>Conn</surname><given-names>D</given-names></string-name></person-group>. <article-title>Apathy in dementia: an examination of the psychometric properties of the Apathy Evaluation Scale</article-title>. <source>J Neuropsychiatry Clin Neurosci</source>. <year>2007</year>;<volume>19</volume>(<issue>1</issue>):<fpage>57</fpage>-<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.1176/jnp.2007.19.1.57</pub-id><?supplied-pmid 17308228?><pub-id pub-id-type="pmid">17308228</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ishii</surname><given-names>S</given-names></string-name>, <string-name><surname>Weintraub</surname><given-names>N</given-names></string-name>, <string-name><surname>Mervis</surname><given-names>JR</given-names></string-name></person-group>. <article-title>Apathy: a common psychiatric syndrome in the elderly</article-title>. <source>J Am Med Dir Assoc</source>. <year>2009</year>;<volume>10</volume>(<issue>6</issue>):<fpage>381</fpage>-<lpage>393</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jamda.2009.03.007</pub-id><?supplied-pmid 19560715?><pub-id pub-id-type="pmid">19560715</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mohammad</surname><given-names>D</given-names></string-name>, <string-name><surname>Ellis</surname><given-names>C</given-names></string-name>, <string-name><surname>Rau</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Psychometric properties of apathy scales in dementia: a systematic review</article-title>. <source>J Alzheimers Dis</source>. <year>2018</year>;<volume>66</volume>(<issue>3</issue>):<fpage>1065</fpage>-<lpage>1082</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-180485</pub-id><?supplied-pmid 30400094?><pub-id pub-id-type="pmid">30400094</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Clarke</surname><given-names>DE</given-names></string-name>, <string-name><surname>van Reekum</surname><given-names>R</given-names></string-name>, <string-name><surname>Patel</surname><given-names>J</given-names></string-name>, <string-name><surname>Simard</surname><given-names>M</given-names></string-name>, <string-name><surname>Gomez</surname><given-names>E</given-names></string-name>, <string-name><surname>Streiner</surname><given-names>DL</given-names></string-name></person-group>. <article-title>An appraisal of the psychometric properties of the clinician version of the Apathy Evaluation Scale (AES-C)</article-title>. <source>Int J Methods Psychiatr Res</source>. <year>2007</year>;<volume>16</volume>(<issue>2</issue>):<fpage>97</fpage>-<lpage>110</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mpr.207</pub-id><?supplied-pmid 17623389?><pub-id pub-id-type="pmid">17623389</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Respino</surname><given-names>M</given-names></string-name>, <string-name><surname>Hoptman</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Victoria</surname><given-names>LW</given-names></string-name>, <etal/></person-group>. <article-title>Cognitive control network homogeneity and executive functions in late-life depression</article-title>. <source>Biol Psychiatry Cogn Neurosci Neuroimaging</source>. <year>2020</year>;<volume>5</volume>(<issue>2</issue>):<fpage>213</fpage>-<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpsc.2019.10.013</pub-id><?supplied-pmid 31901436?><pub-id pub-id-type="pmid">31901436</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Riddle</surname><given-names>M</given-names></string-name>, <string-name><surname>Potter</surname><given-names>GG</given-names></string-name>, <string-name><surname>McQuoid</surname><given-names>DR</given-names></string-name>, <string-name><surname>Steffens</surname><given-names>DC</given-names></string-name>, <string-name><surname>Beyer</surname><given-names>JL</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>WD</given-names></string-name></person-group>. <article-title>Longitudinal cognitive outcomes of clinical phenotypes of late-life depression</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2017</year>;<volume>25</volume>(<issue>10</issue>):<fpage>1123</fpage>-<lpage>1134</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jagp.2017.03.016</pub-id><?supplied-pmid 28479153?><pub-id pub-id-type="pmid">28479153</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Butters</surname><given-names>MA</given-names></string-name>, <string-name><surname>Young</surname><given-names>JB</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>O</given-names></string-name>, <etal/></person-group>. <article-title>Pathways linking late-life depression to persistent cognitive impairment and dementia</article-title>. <source>Dialogues Clin Neurosci</source>. <year>2008</year>;<volume>10</volume>(<issue>3</issue>):<fpage>345</fpage>-<lpage>357</lpage>. doi:<pub-id pub-id-type="doi">10.31887/DCNS.2008.10.3/mabutters</pub-id><?supplied-pmid 18979948?><pub-id pub-id-type="pmid">18979948</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lingjaerde</surname><given-names>O</given-names></string-name>, <string-name><surname>Ahlfors</surname><given-names>UG</given-names></string-name>, <string-name><surname>Bech</surname><given-names>P</given-names></string-name>, <string-name><surname>Dencker</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Elgen</surname><given-names>K</given-names></string-name></person-group>. <article-title>The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients</article-title>. <source>Acta Psychiatr Scand Suppl</source>. <year>1987</year>;<volume>334</volume>(<issue>334</issue>):<fpage>1</fpage>-<lpage>100</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0447.1987.tb10566.x</pub-id><?supplied-pmid 2887090?><pub-id pub-id-type="pmid">2887090</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Glasser</surname><given-names>MF</given-names></string-name>, <string-name><surname>Coalson</surname><given-names>TS</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>EC</given-names></string-name>, <etal/></person-group>. A multi-modal parcellation of human cerebral cortex. <source>Nature</source>. 201611;536(7615):171-178. doi:<pub-id pub-id-type="doi">10.1038/nature18933</pub-id><?supplied-pmid 27437579?><pub-id pub-id-type="pmid">27437579</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Shokri-Kojori</surname><given-names>E</given-names></string-name>, <string-name><surname>Wang</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Wiers</surname><given-names>CE</given-names></string-name>, <etal/></person-group>. <article-title>β-Amyloid accumulation in the human brain after one night of sleep deprivation</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2018</year>;<volume>115</volume>(<issue>17</issue>):<fpage>4483</fpage>-<lpage>4488</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1721694115</pub-id><?supplied-pmid 29632177?><pub-id pub-id-type="pmid">29632177</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ott</surname><given-names>CV</given-names></string-name>, <string-name><surname>Macoveanu</surname><given-names>J</given-names></string-name>, <string-name><surname>Bowie</surname><given-names>CR</given-names></string-name>, <etal/></person-group>. <article-title>Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trial</article-title>. <source>Neuropsychopharmacology</source>. <year>2021</year>;46(<issue>6</issue>):<fpage>1113</fpage>-<lpage>1121</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41386-020-00901-7</pub-id><?supplied-pmid 33168945?><pub-id pub-id-type="pmid">33168945</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Saunders</surname><given-names>J</given-names></string-name>, <string-name><surname>Carlson</surname><given-names>HL</given-names></string-name>, <string-name><surname>Cortese</surname><given-names>F</given-names></string-name>, <string-name><surname>Goodyear</surname><given-names>BG</given-names></string-name>, <string-name><surname>Kirton</surname><given-names>A</given-names></string-name></person-group>. <article-title>Imaging functional motor connectivity in hemiparetic children with perinatal stroke</article-title>. <source>Hum Brain Mapp</source>. <year>2019</year>;<volume>40</volume>(<issue>5</issue>):<fpage>1632</fpage>-<lpage>1642</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.24474</pub-id><?supplied-pmid 30447082?><pub-id pub-id-type="pmid">30447082</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gao</surname><given-names>F</given-names></string-name>, <string-name><surname>Yin</surname><given-names>X</given-names></string-name>, <string-name><surname>Edden</surname><given-names>RAE</given-names></string-name>, <etal/></person-group>. <article-title>Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis</article-title>. <source>Hippocampus</source>. <year>2018</year>;<volume>28</volume>(<issue>11</issue>):<fpage>813</fpage>-<lpage>823</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hipo.23001</pub-id><?supplied-pmid 30069963?><pub-id pub-id-type="pmid">30069963</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Li</surname><given-names>R</given-names></string-name>, <string-name><surname>Liao</surname><given-names>W</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Y</given-names></string-name>, <etal/></person-group>. <article-title>Differential patterns of dynamic functional connectivity variability of striato-cortical circuitry in children with benign epilepsy with centrotemporal spikes</article-title>. <source>Hum Brain Mapp</source>. <year>2018</year>;<volume>39</volume>(<issue>3</issue>):<fpage>1207</fpage>-<lpage>1217</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.23910</pub-id><?supplied-pmid 29206330?><pub-id pub-id-type="pmid">29206330</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lu</surname><given-names>F</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name><surname>Xu</surname><given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Decreased interhemispheric resting-state functional connectivity in male adolescents with conduct disorder</article-title>. <source>Brain Imaging Behav</source>. <year>2021</year>;<volume>15</volume>(<issue>3</issue>):<fpage>1201</fpage>-<lpage>1210</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11682-020-00320-8</pub-id><?supplied-pmid 32623563?><pub-id pub-id-type="pmid">32623563</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Wedeen</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Tseng</surname><given-names>WYI</given-names></string-name></person-group>. <article-title>Estimation of fiber orientation and spin density distribution by diffusion deconvolution</article-title>. <source>Neuroimage</source>. <year>2011</year>;<volume>55</volume>(<issue>3</issue>):<fpage>1054</fpage>-<lpage>1062</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.11.087</pub-id><?supplied-pmid 21232611?><pub-id pub-id-type="pmid">21232611</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Wedeen</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Tseng</surname><given-names>WY</given-names></string-name></person-group>. <article-title>Generalized q-sampling imaging</article-title>. <source>IEEE Trans Med Imaging</source>. <year>2010</year>;<volume>29</volume>(<issue>9</issue>):<fpage>1626</fpage>-<lpage>1635</lpage>. doi:<pub-id pub-id-type="doi">10.1109/TMI.2010.2045126</pub-id><?supplied-pmid 20304721?><pub-id pub-id-type="pmid">20304721</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Vettel</surname><given-names>JM</given-names></string-name>, <string-name><surname>Singh</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Quantifying differences and similarities in whole-brain white matter architecture using local connectome fingerprints</article-title>. <source>PLoS Comput Biol</source>. <year>2016</year>;<volume>12</volume>(<issue>11</issue>):<elocation-id>e1005203</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1005203</pub-id><?supplied-pmid 27846212?><pub-id pub-id-type="pmid">27846212</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Verstynen</surname><given-names>TD</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fernández-Miranda</surname><given-names>JC</given-names></string-name>, <string-name><surname>Tseng</surname><given-names>WYI</given-names></string-name></person-group>. <article-title>Deterministic diffusion fiber tracking improved by quantitative anisotropy</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>11</issue>):<elocation-id>e80713</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0080713</pub-id><?supplied-pmid 24348913?><pub-id pub-id-type="pmid">24348913</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Panesar</surname><given-names>S</given-names></string-name>, <string-name><surname>Barrios</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Automatic removal of false connections in diffusion MRI tractography using topology-informed pruning (TIP)</article-title>. <source>Neurotherapeutics</source>. <year>2019</year>;<volume>16</volume>(<issue>1</issue>):<fpage>52</fpage>-<lpage>58</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13311-018-0663-y</pub-id><?supplied-pmid 30218214?><pub-id pub-id-type="pmid">30218214</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yeh</surname><given-names>FC</given-names></string-name>, <string-name><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name><surname>Hitchens</surname><given-names>TK</given-names></string-name>, <string-name><surname>Wu</surname><given-names>YL</given-names></string-name></person-group>. <article-title>Mapping immune cell infiltration using restricted diffusion MRI</article-title>. <source>Magn Reson Med</source>. <year>2017</year>;<volume>77</volume>(<issue>2</issue>):<fpage>603</fpage>-<lpage>612</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mrm.26143</pub-id><?supplied-pmid 26843524?><pub-id pub-id-type="pmid">26843524</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kyle</surname><given-names>PR</given-names></string-name>, <string-name><surname>Lemming</surname><given-names>OM</given-names></string-name>, <string-name><surname>Timmerby</surname><given-names>N</given-names></string-name>, <string-name><surname>Søndergaard</surname><given-names>S</given-names></string-name>, <string-name><surname>Andreasson</surname><given-names>K</given-names></string-name>, <string-name><surname>Bech</surname><given-names>P</given-names></string-name></person-group>. <article-title>The validity of the different versions of the Hamilton Depression Scale in separating remission rates of placebo and antidepressants in clinical trials of major depression</article-title>. <source>J Clin Psychopharmacol</source>. <year>2016</year>;<volume>36</volume>(<issue>5</issue>):<fpage>453</fpage>-<lpage>456</lpage>. doi:<pub-id pub-id-type="doi">10.1097/JCP.0000000000000557</pub-id><?supplied-pmid 27525966?><pub-id pub-id-type="pmid">27525966</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kraemer</surname><given-names>HC</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>GT</given-names></string-name>, <string-name><surname>Fairburn</surname><given-names>CG</given-names></string-name>, <string-name><surname>Agras</surname><given-names>WS</given-names></string-name></person-group>. <article-title>Mediators and moderators of treatment effects in randomized clinical trials</article-title>. <source>Arch Gen Psychiatry</source>. <year>2002</year>;<volume>59</volume>(<issue>10</issue>):<fpage>877</fpage>-<lpage>883</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.59.10.877</pub-id><?supplied-pmid 12365874?><pub-id pub-id-type="pmid">12365874</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r57">
                <label>57</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Hayes</surname><given-names>AF</given-names></string-name></person-group>. <source>Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach</source>. 2nd ed. Guilford Publications; 2018.</mixed-citation>
              </ref>
              <ref id="zoi220679r58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Husain</surname><given-names>M</given-names></string-name>, <string-name><surname>Roiser</surname><given-names>JP</given-names></string-name></person-group>. <article-title>Neuroscience of apathy and anhedonia: a transdiagnostic approach</article-title>. <source>Nat Rev Neurosci</source>. <year>2018</year>;<volume>19</volume>(<issue>8</issue>):<fpage>470</fpage>-<lpage>484</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41583-018-0029-9</pub-id><?supplied-pmid 29946157?><pub-id pub-id-type="pmid">29946157</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Tay</surname><given-names>J</given-names></string-name>, <string-name><surname>Lisiecka-Ford</surname><given-names>DM</given-names></string-name>, <string-name><surname>Hollocks</surname><given-names>MJ</given-names></string-name>, <etal/></person-group>. <article-title>Network neuroscience of apathy in cerebrovascular disease</article-title>. <source>Prog Neurobiol</source>. <year>2020</year>;<volume>188</volume>:<elocation-id>101785</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.pneurobio.2020.101785</pub-id><?supplied-pmid 32151533?><pub-id pub-id-type="pmid">32151533</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Le Heron</surname><given-names>C</given-names></string-name>, <string-name><surname>Apps</surname><given-names>MAJ</given-names></string-name>, <string-name><surname>Husain</surname><given-names>M</given-names></string-name></person-group>. <article-title>The anatomy of apathy: a neurocognitive framework for amotivated behaviour</article-title>. <source>Neuropsychologia</source>. <year>2018</year>;<volume>118</volume>(<issue>pt B</issue>):<fpage>54</fpage>-<lpage>67</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2017.07.003</pub-id><?supplied-pmid 28689673?><pub-id pub-id-type="pmid">28689673</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Raimo</surname><given-names>S</given-names></string-name>, <string-name><surname>Santangelo</surname><given-names>G</given-names></string-name>, <string-name><surname>D’Iorio</surname><given-names>A</given-names></string-name>, <string-name><surname>Trojano</surname><given-names>L</given-names></string-name>, <string-name><surname>Grossi</surname><given-names>D</given-names></string-name></person-group>. <article-title>Neural correlates of apathy in patients with neurodegenerative disorders: an activation likelihood estimation (ALE) meta-analysis</article-title>. <source>Brain Imaging Behav</source>. <year>2019</year>;<volume>13</volume>(<issue>6</issue>):<fpage>1815</fpage>-<lpage>1834</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11682-018-9959-0</pub-id><?supplied-pmid 30238208?><pub-id pub-id-type="pmid">30238208</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Uddin</surname><given-names>LQ</given-names></string-name>, <string-name><surname>Nomi</surname><given-names>JS</given-names></string-name>, <string-name><surname>Hébert-Seropian</surname><given-names>B</given-names></string-name>, <string-name><surname>Ghaziri</surname><given-names>J</given-names></string-name>, <string-name><surname>Boucher</surname><given-names>O</given-names></string-name></person-group>. <article-title>Structure and function of the human insula</article-title>. <source>J Clin Neurophysiol</source>. <year>2017</year>;<volume>34</volume>(<issue>4</issue>):<fpage>300</fpage>-<lpage>306</lpage>. doi:<pub-id pub-id-type="doi">10.1097/WNP.0000000000000377</pub-id><?supplied-pmid 28644199?><pub-id pub-id-type="pmid">28644199</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kouneiher</surname><given-names>F</given-names></string-name>, <string-name><surname>Charron</surname><given-names>S</given-names></string-name>, <string-name><surname>Koechlin</surname><given-names>E</given-names></string-name></person-group>. Motivation and cognitive control in the human prefrontal cortex. <source>Nature Neurosci</source>. <year>2009</year>;12(7):939-945. doi:<pub-id pub-id-type="doi">10.1038/nn.2321</pub-id><?supplied-pmid 19503087?><pub-id pub-id-type="pmid">19503087</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Chong</surname><given-names>TTJ</given-names></string-name>, <string-name><surname>Apps</surname><given-names>M</given-names></string-name>, <string-name><surname>Giehl</surname><given-names>K</given-names></string-name>, <string-name><surname>Sillence</surname><given-names>A</given-names></string-name>, <string-name><surname>Grima</surname><given-names>LL</given-names></string-name>, <string-name><surname>Husain</surname><given-names>M</given-names></string-name></person-group>. <article-title>Neurocomputational mechanisms underlying subjective valuation of effort costs</article-title>. <source>PLoS Biol</source>. <year>2017</year>;<volume>15</volume>(<issue>2</issue>):<elocation-id>e1002598</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.1002598</pub-id><?supplied-pmid 28234892?><pub-id pub-id-type="pmid">28234892</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Saleh</surname><given-names>Y</given-names></string-name>, <string-name><surname>Le Heron</surname><given-names>C</given-names></string-name>, <string-name><surname>Petitet</surname><given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Apathy in small vessel cerebrovascular disease is associated with deficits in effort-based decision making</article-title>. <source>Brain</source>. <year>2021</year>;<volume>144</volume>(<issue>4</issue>):<fpage>1247</fpage>-<lpage>1262</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awab013</pub-id><?supplied-pmid 33734344?><pub-id pub-id-type="pmid">33734344</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bonnelle</surname><given-names>V</given-names></string-name>, <string-name><surname>Manohar</surname><given-names>S</given-names></string-name>, <string-name><surname>Behrens</surname><given-names>T</given-names></string-name>, <string-name><surname>Husain</surname><given-names>M</given-names></string-name></person-group>. <article-title>Individual differences in premotor brain systems underlie behavioral apathy</article-title>. <source>Cereb Cortex</source>. <year>2016</year>;<volume>26</volume>(<issue>2</issue>):<fpage>807</fpage>-<lpage>819</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhv247</pub-id><?supplied-pmid 26564255?><pub-id pub-id-type="pmid">26564255</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Huskey</surname><given-names>R</given-names></string-name>, <string-name><surname>Craighead</surname><given-names>B</given-names></string-name>, <string-name><surname>Miller</surname><given-names>MB</given-names></string-name>, <string-name><surname>Weber</surname><given-names>R</given-names></string-name></person-group>. <article-title>Does intrinsic reward motivate cognitive control? a naturalistic-fMRI study based on the synchronization theory of flow</article-title>. <source>Cogn Affect Behav Neurosci</source>. <year>2018</year>;<volume>18</volume>(<issue>5</issue>):<fpage>902</fpage>-<lpage>924</lpage>. doi:<pub-id pub-id-type="doi">10.3758/s13415-018-0612-6</pub-id><?supplied-pmid 29923098?><pub-id pub-id-type="pmid">29923098</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r68">
                <label>68</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Morris</surname><given-names>LS</given-names></string-name>, <string-name><surname>Kundu</surname><given-names>P</given-names></string-name>, <string-name><surname>Dowell</surname><given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>Fronto-striatal organization: defining functional and microstructural substrates of behavioural flexibility</article-title>. <source>Cortex</source>. <year>2016</year>;<volume>74</volume>:<fpage>118</fpage>-<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cortex.2015.11.004</pub-id><?supplied-pmid 26673945?><pub-id pub-id-type="pmid">26673945</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r69">
                <label>69</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Le Heron</surname><given-names>C</given-names></string-name>, <string-name><surname>Holroyd</surname><given-names>CB</given-names></string-name>, <string-name><surname>Salamone</surname><given-names>J</given-names></string-name>, <string-name><surname>Husain</surname><given-names>M</given-names></string-name></person-group>. <article-title>Brain mechanisms underlying apathy</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2019</year>;<volume>90</volume>(<issue>3</issue>):<fpage>302</fpage>-<lpage>312</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2018-318265</pub-id><?supplied-pmid 30366958?><pub-id pub-id-type="pmid">30366958</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r70">
                <label>70</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Montoya-Murillo</surname><given-names>G</given-names></string-name>, <string-name><surname>Ibarretxe-Bilbao</surname><given-names>N</given-names></string-name>, <string-name><surname>Peña</surname><given-names>J</given-names></string-name>, <string-name><surname>Ojeda</surname><given-names>N</given-names></string-name></person-group>. <article-title>The impact of apathy on cognitive performance in the elderly</article-title>. <source>Int J Geriatr Psychiatry</source>. <year>2019</year>;<volume>34</volume>(<issue>5</issue>):<fpage>657</fpage>-<lpage>665</lpage>. doi:<pub-id pub-id-type="doi">10.1002/gps.5062</pub-id><?supplied-pmid 30672026?><pub-id pub-id-type="pmid">30672026</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r71">
                <label>71</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bubb</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Metzler-Baddeley</surname><given-names>C</given-names></string-name>, <string-name><surname>Aggleton</surname><given-names>JP</given-names></string-name></person-group>. <article-title>The cingulum bundle: anatomy, function, and dysfunction</article-title>. <source>Neurosci Biobehav Rev</source>. <year>2018</year>;<volume>92</volume>:<fpage>104</fpage>-<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.05.008</pub-id><?supplied-pmid 29753752?><pub-id pub-id-type="pmid">29753752</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r72">
                <label>72</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Beckmann</surname><given-names>M</given-names></string-name>, <string-name><surname>Johansen-Berg</surname><given-names>H</given-names></string-name>, <string-name><surname>Rushworth</surname><given-names>MFS</given-names></string-name></person-group>. Connectivity-based parcellation of human cingulate cortex and its relation to functional specialization. <source>J Neurosci</source>. 2009;29(4):1175-1190. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3328-08.2009</pub-id><?supplied-pmid 19176826?><pub-id pub-id-type="pmid">19176826</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r73">
                <label>73</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname><given-names>D</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Subcomponents and connectivity of the inferior fronto-occipital fasciculus revealed by diffusion spectrum imaging fiber tracking</article-title>. <source>Front Neuroanat</source>. <year>2016</year>;<volume>10</volume>(<issue>SEP</issue>):<fpage>88</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnana.2016.00088</pub-id><?supplied-pmid 27721745?><pub-id pub-id-type="pmid">27721745</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220679r74">
                <label>74</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Nomi</surname><given-names>JS</given-names></string-name>, <string-name><surname>Schettini</surname><given-names>E</given-names></string-name>, <string-name><surname>Broce</surname><given-names>I</given-names></string-name>, <string-name><surname>Dick</surname><given-names>AS</given-names></string-name>, <string-name><surname>Uddin</surname><given-names>LQ</given-names></string-name></person-group>. <article-title>Structural connections of functionally defined human insular subdivisions</article-title>. <source>Cereb Cortex</source>. <year>2018</year>;<volume>28</volume>(<issue>10</issue>):<fpage>3445</fpage>-<lpage>3456</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhx211</pub-id><?supplied-pmid 28968768?><pub-id pub-id-type="pmid">28968768</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZOI220679-1">
              <supplementary-material id="note-ZOI220679-1-s" position="float" content-type="local-data">
                <label>Supplement 1.</label>
                <caption>
                  <p>
eMethods.
</p>
                  <p>
eResults.
</p>
                  <p><bold>eTable.</bold> Coordinates (MNI) of Clusters That Differed in Functional Connectivity With Salience Network Seeds Between Participants With and Without Apathy</p>
                  <p><bold>eFigure 1.</bold> Differences in Dorsal Anterior Cingulate (dACC) Connectivity Associated With Apathy in Older Adults With Depression</p>
                  <p><bold>eFigure 2.</bold> Differences in Structural Connectivity Associated With Apathy in Older Adults With Depression</p>
                  <p><bold>eFigure 3.</bold> Associations Between Pretreatment Dorsal Anterior Cingulate Cortex (dACC) Connectivity and Change in Cognitive Performance Following Escitalopram Treatment</p>
                  <p>
eReferences.
</p>
                </caption>
                <media xlink:href="jamanetwopen-e2224142-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 2.</label>
                <caption>
                  <p>
Data Sharing Statement
</p>
                </caption>
                <media xlink:href="jamanetwopen-e2224142-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
